Product Information
IRBESARTAN 75 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0807 per EA under NDC 29300021219. Its NADAC has been published 113 times since Jan 31, 2024.
Strength
75 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300021219
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203020On Market Since
12/7/2015
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 75 MG TABLET has been published 113 times since Jan 31, 2024, and over the history we have for it it has declined 42.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0807 per EA |
|---|---|
| All-time high | $0.1509 (Oct 16, 2024) |
| All-time low | $0.0800 (May 20, 2026) |
| 52-week high | $0.1157 |
| 52-week low | $0.0800 |
| Median price | $0.1118 |
| Average price | $0.1112 |
| Largest weekly change | -20.7% (Nov 20, 2024) |
| Weeks tracked | 113 |
| Tracking since | Jan 31, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 75 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0807 per EA (NDC 29300021219), effective Jun 24, 2026.
How has the price of IRBESARTAN 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 75 MG TABLET has declined 42.8%. It has been tracked across 113 weekly CMS publications since Jan 31, 2024.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 75 MG TABLET?
Since Jan 31, 2024, the NADAC for IRBESARTAN 75 MG TABLET has ranged from a low of $0.0800 (May 20, 2026) to a high of $0.1509 (Oct 16, 2024), with a median of $0.1118 per EA.
Are there cheaper alternatives to IRBESARTAN 75 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as IRBESARTAN 75 MG TABLET, but none are currently priced below it.
Who manufactures IRBESARTAN 75 MG TABLET?
IRBESARTAN 75 MG TABLET (NDC 29300021219) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification